CAI
Caris Life Sciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.09B
P/E Ratio
—
EPS
$-2.76
Beta
—
52W High
$42.50
52W Low
$14.19
50-Day MA
$17.86
200-Day MA
$24.39
Dividend Yield
—
Profit Margin
3.75%
Forward P/E
47.39
PEG Ratio
—
About Caris Life Sciences, Inc. Common Stock
CAI International, Inc. is a transportation finance company in the United States, Switzerland, France, Korea, Singapore, Rest of Asia, Rest of Europe, and internationally. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $907.29M |
| Gross Profit (TTM) | $625.32M |
| EBITDA | $128.98M |
| Operating Margin | 2.44% |
| Return on Equity | 28.30% |
| Return on Assets | 9.32% |
| Revenue/Share (TTM) | $3.96 |
| Book Value | $2.10 |
| Price-to-Book | 8.57 |
| Price-to-Sales (TTM) | 5.61 |
| EV/Revenue | 5.17 |
| EV/EBITDA | 42.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 78.80% |
| Shares Outstanding | $282.68M |
| Float | $103.39M |
| % Insiders | 48.51% |
| % Institutions | 56.66% |
Historical Volatility
HV 10-Day
81.33%
HV 20-Day
69.31%
HV 30-Day
94.98%
HV 60-Day
80.74%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($27.83 target)
1
Strong Buy10
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026